Market Data
Market Cap₹9.72 Cr.
52W High₹11.01
Current Price₹9.26
52W Low₹3.57
Down from 52W High15.9 %
Face Value₹10
Performance
ROCE0.98 %
ROE0.98 %
EPS Prev Qtr₹0.01
EPS Last Year₹0.01
Book Value₹3
Financial Health
Debt/Equity0
Debt/Profit0
Total Assets₹3.841 Cr.
Earning Power0.78 %
Valuation
Stock P/E308.67
Industry P/E40.99
Price to Book3.18
Price to Sales22.6
Graham Number₹1.4
Key Metrics
Face Value
₹10
About Looks Health Services Ltd
Healthcare · Healthcare
Looks Health Services Ltd is listed on NSE in the Healthcare / Healthcare sector. Face value ₹10. Market cap ₹9.72 Cr.
Price Chart
Peer Comparison
| Name | CMP | P/E | Market Cap | Div Yield | NP Qtr | Qtr Profit Var% | Sales Qtr | Qtr Sales Var% | ROCE% | Debt/Eq |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | - | 60.97 | ₹1,27,421.96 Cr | 0.23% | ₹2,172 Cr | - | ₹26,429.9 Cr | - | 22.05% | 0.6 |
| Max Healthcare Institute Ltd | - | 66.77 | ₹97,411.97 Cr | 0.2% | ₹1,457.4 Cr | - | ₹8,712.05 Cr | - | 14.38% | 0.27 |
| Manipal Health Enterprises Ltd | - | - | ₹94,970.23 Cr | - | - | - | - | - | - | 1.25 |
| Aster DM Quality Care Ltd | - | 121 | ₹65,183.66 Cr | 0.4% | ₹362.82 Cr | - | ₹4,876.03 Cr | - | 12.95% | 0.17 |
| Fortis Healthcare Ltd | - | 59.91 | ₹62,782.32 Cr | 0.12% | ₹1,070.21 Cr | - | ₹9,506.15 Cr | - | 13.34% | 0.29 |
| Global Health Ltd | - | 69.27 | ₹38,550.84 Cr | - | ₹552.33 Cr | - | ₹4,683.41 Cr | - | 21.87% | 0.1 |
| Narayana Hrudayalaya Ltd | - | 45.26 | ₹37,159.95 Cr | - | ₹816.55 Cr | - | ₹9,072.4 Cr | - | 13.65% | 1.07 |
| Dr Lal Pathlabs Ltd | - | 46.81 | ₹32,548.55 Cr | 1.26% | ₹546.3 Cr | - | ₹2,890.8 Cr | - | 29.55% | 0 |
| Krishna Institute of Medical Sciences Ltd | - | 150.24 | ₹32,180.9 Cr | - | ₹194.4 Cr | - | ₹4,212.5 Cr | - | 9.66% | 1.44 |
| Poly Medicure Ltd | - | 52.64 | ₹16,587.48 Cr | 0.21% | ₹312.92 Cr | - | ₹1,997.43 Cr | - | 15.07% | 0.06 |
| Dr Agarwals Health Care Ltd | - | 107.57 | ₹15,991.79 Cr | - | ₹185.1 Cr | - | ₹2,206.68 Cr | - | 16.46% | 0.08 |
| Vijaya Diagnostic Centre Ltd | - | 82.27 | ₹15,431.94 Cr | 0.13% | ₹187.49 Cr | - | ₹857.13 Cr | - | 36.21% | 0 |
| Syngene International Ltd | - | 68.32 | ₹15,167.87 Cr | 0.33% | ₹221 Cr | - | ₹3,600.2 Cr | - | 6.95% | 0 |
| Indegene Ltd | - | 36.68 | ₹14,769.29 Cr | 0.37% | ₹400.9 Cr | - | ₹3,812.8 Cr | - | 17.45% | 0 |
| Rainbow Childrens Medicare Ltd | - | 48.85 | ₹13,947.12 Cr | 0.25% | ₹290.28 Cr | - | ₹1,820.14 Cr | - | 27.05% | 0 |
| Molbio Diagnostics Ltd | - | - | ₹13,924.73 Cr | - | - | - | - | - | - | 0.35 |
| Park Medi World Ltd | - | 38.3 | ₹11,945.05 Cr | - | ₹296.75 Cr | - | ₹1,756.29 Cr | - | 19.17% | 0.11 |
| Metropolis Healthcare Ltd | - | 24.51 | ₹11,863.54 Cr | 0.87% | ₹202.82 Cr | - | ₹1,710 Cr | - | 19.8% | 0.01 |
| Yatharth Hospital & Trauma Care Services Ltd | - | 58.5 | ₹10,596.57 Cr | - | ₹174.45 Cr | - | ₹1,334.1 Cr | - | 11.7% | 0.14 |
| Healthcare Global Enterprises Ltd | - | 446.68 | ₹10,336.94 Cr | - | ₹33.26 Cr | - | ₹2,627.35 Cr | - | 9.41% | 0.68 |
Quarterly Results
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Sales | 0.07 | 0.12 | 0.12 | 0.12 |
| ↳ QoQ Growth | - | +71.4% | 0.0% | 0.0% |
| Expenses | 0.06 | 0.11 | 0.11 | 0.12 |
| Operating Profit | 0.01 | 0.01 | 0.01 | 0 |
| OPM % | 14.29% | 8.33% | 8.33% | 0% |
| Other Income | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 0.04 | 0.04 | 0.03 | 0.04 |
| EBITDA | 0.05 | 0.05 | 0.04 | 0.04 |
| EBITDA Margin % | 71.43% | 41.67% | 33.33% | 33.33% |
| Profit Before Tax | 0.01 | 0.01 | 0.01 | 0 |
| Tax % | 0% | 0% | 0% | - |
| Net Profit | 0.01 | 0.01 | 0.01 | 0 |
| ↳ QoQ Growth | - | 0.0% | 0.0% | -100.0% |
| EPS | 0.01 | 0.01 | 0.01 | 0 |
Balance Sheet
| Mar 2012 | |
|---|---|
| Equity Capital | 3.125 |
| Reserves | -0.0634615 |
| Borrowings | 0 |
| Other Liabilities | 0.78 |
| Total Liabilities | 3.8407729 |
| Fixed Assets | 2.1175158 |
| CWIP | 0 |
| Investments | 0 |
| Other Assets | 1.72 |
| Total Assets | 3.8407729 |
Cash Flows
| Mar 2012 | |
|---|---|
| Cash from Operating Activity | -0.7980354 |
| Cash from Investing Activity | -2.123005 |
| Cash from Financing Activity | 3.5 |
| Net Cash Flow | 0.5789597 |
Shareholding Pattern
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Promoters % | 10.38% | 0% | 0% | 0% |
| FIIs % | 9.31% | 16.99% | 16.99% | 16.99% |
| DIIs % | 0% | 0% | 0% | 0% |
| Public % | 72.77% | 74.29% | 73.5% | 73.8% |
| No. of Shareholders | 11,420 | 11,264 | 11,629 | 11,235 |